The company aims to conduct biotechnological research, development, and production of various cell lines (mammals, fish, and birds), as well as other components such as culture media, media supplements, and microcarriers for the production of cultivated meat, other protein masses, and cultivated fat. Furthermore, the company's purpose includes further research in the field of cellular agriculture and the development, production, manufacturing, marketing, and distribution of components and products in the field of pet food based on the aforementioned research; development and production as well as the marketing, distribution, and sale of any by-products. The company may engage in all commercial, contractual, and financial transactions that are suitable for promoting the company's purpose or are directly or indirectly related thereto. The company may establish branches and subsidiaries both domestically and abroad and may invest in other companies both domestically and abroad. The company may acquire, hold, and dispose of intellectual property rights and licenses of any kind. The company may acquire, manage, and dispose of real estate. The company may also arrange financing for its own account or for the account of others and may grant direct or indirect financing to its direct or indirect subsidiaries as well as to third parties, including their direct or indirect shareholders and their direct or indirect subsidiaries, provide securities of any kind for its own liabilities and those of other companies (including direct or indirect shareholders of the company or companies in which these shareholders are directly or indirectly involved) by way of pledge on or fiduciary transfer or assignment of the company's assets, or provide guarantees, enter into suretyships, or secure or guarantee the obligations of these other companies in any other manner, whether for a fee or not. Furthermore, it may engage in liquidity balancing/concentration of net liquidity (cash pooling) with the aforementioned companies or join such an arrangement, including periodic account balancing (balancing). This may also be done on preferential terms without interest, excluding the company's profit-seeking nature and assuming clustering risks.